1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol and Anoxemia

1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol has been researched along with Anoxemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fan, L; Hu, L; Peng, G; Qiao, B; Tu, Q; Wang, Y; Xia, Z; Xiong, Y; Ye, Q	1

Other Studies

1 other study(ies) available for 1-hexadecyl-3-trifluoroethylglycero-sn-2-phosphomethanol and Anoxemia

Article	Year
Peroxiredoxin 6 attenuates ischemia‑ and hypoxia‑induced liver damage of brain‑dead donors. Molecular medicine reports, 2016, Volume: 13, Issue:1 Topics: Blotting, Western; Brain Death; Cell Line; Cytoprotection; Glycerophosphates; Humans; Hypoxia; Intracellular Space; Ischemia; Liver; NF-kappa B; Peroxiredoxin VI; Phospholipase A2 Inhibitors; Phospholipases A2; Reactive Oxygen Species; Signal Transduction; Tissue Donors; Transfection	2016

Article

Year

Peroxiredoxin 6 attenuates ischemia‑ and hypoxia‑induced liver damage of brain‑dead donors.

Molecular medicine reports, 2016, Volume: 13, Issue:1

Topics: Blotting, Western; Brain Death; Cell Line; Cytoprotection; Glycerophosphates; Humans; Hypoxia; Intracellular Space; Ischemia; Liver; NF-kappa B; Peroxiredoxin VI; Phospholipase A2 Inhibitors; Phospholipases A2; Reactive Oxygen Species; Signal Transduction; Tissue Donors; Transfection

2016